AI
| Followers | 55 |
| Posts | 2312 |
| Boards Moderated | 0 |
| Alias Born | 06/28/2012 |
Wednesday, September 25, 2013 7:42:43 AM
Great post mac, eyes on the prize. When I get some time, I am going to make a post explaining why I feel that the slow and steady climb in dose escalation in the Dana Farber trial will be a huge win for shareholders in the long term. There are specific advnatages there, but it's easy to overlook when you keep staring at the finish line off in the distance through binoculars. 
